PolyPeptide Group AG (PPGN) — Switzerland Stock Chart & News | StockAdder

(PPGN)

PolyPeptide Group AG

Live chart and latest PPGN stock news.

Market ETF → EWL Switzerland

Chart powered byTradingView— professional charts for every trader.Try it free →

PPGN News

PolyPeptide Confirms Strategic Review Amid Takeover Speculation

Apr 14, 2026 simplywall.st

At CHF28.15, Is It Time To Put PolyPeptide Group AG (VTX:PPGN) On Your Watch List?

Jan 11, 2026 Yahoo Finance

While individual investors own 20% of PolyPeptide Group AG (VTX:PPGN), private companies are its largest shareholders with 56% ownership

Jun 23, 2025 Meyka

PPGN.SW PolyPeptide Group AG (SIX) down 8.82% pre-market 14 Mar 2026: watch CHF23.30 support

Mar 14, 2026 TipRanks

PolyPeptide shareholders back all proposals at 2026 AGM

Apr 8, 2026 simplywall.st

Does PolyPeptide’s 2025 Margin Outlook From Metabolic Therapies Shift The Bull Case For PolyPeptide Group (SWX:PPGN)?

Jan 26, 2026 TipRanks

PolyPeptide lifts revenue and margins as peptide demand fuels major capacity build-out

Mar 11, 2026 simplywall.st

3 European Stocks Estimated To Be Up To 45.4% Below Intrinsic Value

Oct 6, 2025 Yahoo Finance

PolyPeptide Group AG's (VTX:PPGN) top owners are private companies with 56% stake, while 20% is held by individual investors

Dec 29, 2024 TipRanks

PolyPeptide expands EUR 200 million credit line to back growth and capacity plans

Mar 18, 2026 marketscreener.com

PolyPeptide Group AG: Target Price Consensus and Analysts Recommendations | PPGN | CH1110760852

Jun 17, 2021 TipRanks

PolyPeptide Sets 2026 AGM to Confirm Board and Approve 2025 Reports

Mar 16, 2026 marketscreener.com

PolyPeptide Group AG: Shareholders Board Members Managers and Company Profile | CH1110760852

May 8, 2021 marketscreener.com

PolyPeptide Group AG: Fundamental Analysis and Financial Ratings | PPGN | CH1110760852